Advertisement
Screener

ELOXX PHARMACEUTICALS, INC. (ELOX) Other

ELOXX PHARMACEUTICALS, INC. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-05-05: Form 10-Q; Item Shell company; As filed Yes.
  • 2026-03-17: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.01 par value · ELOX · NASDAQ.
  • 2023-11-13: Form 10-Q; Item Current in its reporting; As filed Yes.
  • 2023-08-11: Form 10-Q; Item Current in its reporting; As filed Yes.
FiledFormItemAs filed
2026-05-0510-QShell companyYes
2026-03-1710-KStock registered under Section 12(b)Common Stock, $0.01 par value · ELOX · NASDAQ
2023-11-1310-QCurrent in its reportingYes
2023-08-1110-QCurrent in its reportingYes
2023-05-1210-QCurrent in its reportingYes
2023-03-3110-KStock registered under Section 12(b)Common Stock, $0.01 par value · ELOX · NASDAQ
2023-03-3110-KShell companyYes
2023-03-3110-KCurrent in its reportingYes
2022-11-1010-QCurrent in its reportingYes
2022-08-1210-QCurrent in its reportingYes
2022-05-0610-QStock registered under Section 12(b)Common Stock, $0.01 par value per share · ELOX · The Nasdaq Global Market
2022-05-0610-QCurrent in its reportingYes
2022-03-3010-KStock registered under Section 12(b)Common Stock, $0.01 par value · ELOX · NASDAQ
2022-03-3010-KCurrent in its reportingYes
2021-11-0810-QStock registered under Section 12(b)Common Stock, $0.01 par value per share · ELOX · The Nasdaq Global Market
2021-11-0810-QCurrent in its reportingYes
2021-08-1610-QStock registered under Section 12(b)Common Stock, $0.01 par value per share · ELOX · The Nasdaq Global Market
2021-08-1610-QCurrent in its reportingYes
2021-05-0710-QStock registered under Section 12(b)Common Stock, $0.01 par value per share · ELOX · The Nasdaq Global Market
2021-05-0710-QCurrent in its reportingYes
2021-03-1210-KStock registered under Section 12(b)Common Stock, $0.01 par value · ELOX · NASDAQ
2021-03-1210-KCurrent in its reportingYes
2020-11-0610-QStock registered under Section 12(b)Common Stock, $0.01 par value per share · ELOX · The Nasdaq Global Market
2020-11-0610-QCurrent in its reportingYes
2020-08-0710-QStock registered under Section 12(b)Common Stock, $0.01 par value per share · ELOX · The Nasdaq Global Market
2020-08-0710-QCurrent in its reportingYes
2020-05-0810-QCurrent in its reportingYes
2020-03-0610-KStock registered under Section 12(b)Common Stock, $0.01 par value · ELOX · NASDAQ
2020-03-0610-KCurrent in its reportingYes
2019-11-0610-QCurrent in its reportingYes
2019-08-0710-QCurrent in its reportingYes
2018-03-1610-KCurrent in its reportingYes
2017-10-1310-KCurrent in its reportingYes
2016-10-1310-KCurrent in its reportingYes
2015-10-0910-KCurrent in its reportingYes
2014-09-2910-KCurrent in its reportingYes
2013-09-1110-KCurrent in its reportingYes
2012-10-2610-K/ACurrent in its reportingYes

Similar stocks

Stock NameCountryMarket CapPE Ratio
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
BioStem Technologies, Inc. (BSEM)United States$0.069B
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
EXOZYMES INC. (EXOZ)United States$0.058B
BioAtla, Inc. (BCAB)United States$0.058B-0.21
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
Vaxart, Inc. (VXRT)United States$0.080B3.84
Tevogen Inc. (TVGN)United States$0.049B